Research Library
Triptorelin GnRH research
6 articles to explore, with links to 8 original sources.
About Triptorelin GnRH
Triptorelin is a synthetic gonadotropin-releasing hormone analogue used in GnRH-receptor research.
Explore study findings
The prostate cancer trial that holds triptorelin constant
Triptorelin is a synthetic ten-amino-acid version of gonadotropin-releasing hormone, or GnRH. With sustained exposure it lowers testosterone, and the U.S. prescribing label for Trelstar identifies advanced prostate cancer as its approved use.
2 sources (2026)
What changed when an IVF trial added triptorelin to hCG?
Triptorelin acetate contains a synthetic ten-amino-acid mimic of gonadotropin-releasing hormone, or GnRH.
3 sources (2025, 2026)
What longer follow-up adds to triptorelin research in early puberty
Triptorelin is a synthetic ten-amino-acid agonist of the receptor for gonadotropin-releasing hormone, or GnRH. An extended-release U.S. product, Triptodur, is approved for central precocious puberty in children age two and older.
2 sources (2025, 2026)
Check methods and identity
Two triptorelin formulations compared in girls with early puberty
Triptorelin is a ten-amino-acid synthetic agonist of the receptor for gonadotropin-releasing hormone, or GnRH. Sustained exposure reduces pituitary hormone output.
2 sources (2025, 2026)
How an endometriosis study tested two triptorelin preparations
Triptorelin is a synthetic ten-amino-acid agonist of the receptor for gonadotropin-releasing hormone, or GnRH. Sustained exposure can lower ovarian estrogen production.
3 sources (2025, 2026)
How triptorelin was tested for sustained testosterone suppression
Triptorelin is a synthetic ten-amino-acid mimic of gonadotropin-releasing hormone, or GnRH. Sustained exposure reduces pituitary signaling to the testes and lowers testosterone.
2 sources (2009, 2026)
